Salivary IL ‐8 and sTREM ‐1 in chronic urticaria: A diagnostic test accuracy study
Clinical & Experimental Allergy · 2024
DOI: 10.1111/cea.14457 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical & Experimental Allergy, 2024. Verfasst von Witness Dzobo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University Hospital Southampton NHS Foundation Trust, Southampton, UK. Hauptthemen laut MEDLINE: Chronic Urticaria, Interleukin-8, Triggering Receptor Expressed on Myeloid Cells-1, Saliva. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
- School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.
- School of Biological Sciences, University of Portsmouth, Portsmouth, UK.
ORCID-Profile: Janis K Shute
Zitieren
APA
Dzobo, W., Eren, E., Robson, S., & Shute, J. K. (2024). Salivary IL ‐8 and sTREM ‐1 in chronic urticaria: A diagnostic test accuracy study. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.14457
Vancouver
Dzobo W, Eren E, Robson S, Shute JK. Salivary IL ‐8 and sTREM ‐1 in chronic urticaria: A diagnostic test accuracy study. Clinical & Experimental Allergy. 2024. doi:10.1111/cea.14457
BibTeX
@article{Dzobo2024,
author = {Dzobo, Witness and Eren, Efrem and Robson, Samuel and Shute, Janis K},
title = {Salivary IL ‐8 and sTREM ‐1 in chronic urticaria: A diagnostic test accuracy study},
journal = {Clinical & Experimental Allergy},
year = {2024},
doi = {10.1111/cea.14457}
}
EUVIMED